137 related articles for article (PubMed ID: 21683440)
1. The generation of iPS cells using non-viral magnetic nanoparticle based transfection.
Lee CH; Kim JH; Lee HJ; Jeon K; Lim H; Choi Hy; Lee ER; Park SH; Park JY; Hong S; Kim S; Cho SG
Biomaterials; 2011 Oct; 32(28):6683-91. PubMed ID: 21683440
[TBL] [Abstract][Full Text] [Related]
2. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
[TBL] [Abstract][Full Text] [Related]
5. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.
Onorati M; Camnasio S; Binetti M; Jung CB; Moretti A; Cattaneo E
Mol Cell Neurosci; 2010 Mar; 43(3):287-95. PubMed ID: 20026276
[TBL] [Abstract][Full Text] [Related]
6. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
7. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.
Jin J; Kwon YW; Paek JS; Cho HJ; Yu J; Lee JY; Chu IS; Park IH; Park YB; Kim HS; Kim Y
J Proteome Res; 2011 Mar; 10(3):977-89. PubMed ID: 21175196
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy to derive iPS cells from porcine fibroblasts.
Ruan W; Han J; Li P; Cao S; An Y; Lim B; Li N
Sci China Life Sci; 2011 Jun; 54(6):553-9. PubMed ID: 21706416
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells: a new technology to study human diseases.
Vitale AM; Wolvetang E; Mackay-Sim A
Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
[TBL] [Abstract][Full Text] [Related]
10. Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
Chen M; Sun X; Jiang R; Shen W; Zhong X; Liu B; Qi Y; Huang B; Xiang AP; Ge J
Cell Biol Int; 2009 Dec; 33(12):1268-73. PubMed ID: 19524692
[TBL] [Abstract][Full Text] [Related]
11. Generation of murine hepatic lineage cells from induced pluripotent stem cells.
Gai H; Nguyen DM; Moon YJ; Aguila JR; Fink LM; Ward DC; Ma Y
Differentiation; 2010 Mar; 79(3):171-81. PubMed ID: 20106584
[TBL] [Abstract][Full Text] [Related]
12. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
13. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction.
Tashiro K; Inamura M; Kawabata K; Sakurai F; Yamanishi K; Hayakawa T; Mizuguchi H
Stem Cells; 2009 Aug; 27(8):1802-11. PubMed ID: 19544436
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
16. Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts.
Chen M; Chen Q; Sun X; Shen W; Liu B; Zhong X; Leng Y; Li C; Zhang W; Chai F; Huang B; Gao Q; Xiang AP; Zhuo Y; Ge J
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5970-8. PubMed ID: 20484577
[TBL] [Abstract][Full Text] [Related]
17. Neuronal differentiation potential of mouse induced pluripotent stem cells.
Yao XL; Liu Q; Ye CH; Li ZP; Lu XL; Li PL; Li XB; Li WQ
Neuroreport; 2011 Oct; 22(14):689-95. PubMed ID: 21849916
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
[TBL] [Abstract][Full Text] [Related]
19. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
[TBL] [Abstract][Full Text] [Related]
20. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
